✦ LIBER ✦

The Use of Olmesartan Medoxomil as Monotherapy or in Combination With Other Antihypertensive Agents in Elderly Hypertensive Patients in Japan

✍ Scribed by Ikuo Saito; Toshio Kushiro; Koji Hirata; Yuki Sato; Fumiaki Kobayashi; Kei Sagawa; Katsutoshi Hiramatsu; Masahiro Komiya

Book ID: 114898707
Publisher: Le Jacq Communications, Inc.
Year: 2008
Tongue: English
Weight: 212 KB
Volume: 10
Category: Article
ISSN: 1524-6175
DOI: 10.1111/j.1751-7176.2008.07460.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antihypertensive Efficacy and Safety of

Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic Syndrome

✍ Stefano Omboni, Ettore Malacco, Jean-Michel Mallion, Massimo Volpe 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 512 KB

Comparison of combination therapies, inc

Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension

✍ Kato, Johji; Yokota, Naoto; Tamaki, Noboru; Kariya, Sumito; Kita, Toshihiro; Aya 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 255 KB

Combined modality treatment of locally a

Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy

✍ Paulo M. Hoff; Vicente Valero; Aman U. Buzdar; S. Eva Singletary; Richard L. The 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

The purpose of the current study was to evaluate the objective response rate and possibility of breast-conserving surgery using neoadjuvant tamoxifen in the multimodality treatment, including surgery and radiotherapy, of elderly or frail patients with locally advanced breast carcinoma. ## METHODS.

Autologous stem cell transplantation usi

Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission

✍ Kim, H-J; Min, W-S; Eom, K-S; Park, S-J; Park, Y-H; Kim, D-W; Lee, J-W; Park, C- 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 257 KB